REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/08/2026
Voltar para busca
Dado oficial do USPTO
MY IPS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MY IPS
ST13
US500000079294235Classe
1, 5, 39, 42, 44
Pedido
79294235
Registro
6436457
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
03/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 39, 42, 44
Data de depósito
30/01/2020
Data de registro
03/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/08/2021
Última transação
03/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
JP
Examinador
WEIGLE, KATHERINE CONNOLLY
Unidade examinadora
L10
Localização atual
TMEG LAW OFFICE 101
Titulares e representantes
Titulares
C. F. (pessoa física)
Representantes
Dawn Rudenko Holland & Knight LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 39Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Stem cells for research and scientific purposes; stem cellsother than for medical or veterinary purposes; chemicals used in industry; plant growth regulating preparations; fertilizers; chemical test paperother than for medical purposes
Classe 5
Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paperreagent paper for medical purposes
Classe 39
Storage of frozen living cells; storage of tissuescells and stem cells; warehousing services for deposited articles
Classe 42
Research in the field of stem cells; commissioned cell cultures for scientific purposescustom design and development of cell cultures for scientific use; cell or gene examination in the nature of research on cells and genes; testing and examination on cells; research and development in the field of cells; testingexaminationresearch and development in the field of regenerative medicine; testingexaminationresearch and development of pharmaceuticals; scientific research in the field of culture of cells for transplantation collected from a patient itself; clinical study in the medical field; providing quality assurance services in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on testinginspectionresearch related to medical science using stem cells; providing information related to research and development of pharmaceutical preparations; scientific testinganalysisresearch on treatment method and treatment technique related to medical care; testinginspection or research of cosmetics or foods; design and development of computer hardware and computer software for use in the field of medical science; designing of machinesapparatusinstrumentsincluding their partssystems composed of such machinesapparatus and instruments; designdevelopment or maintenance of computer programs; testing the functionality of machinesapparatusinstruments or research on machines apparatusinstruments; rental of laboratory apparatus and instruments
Classe 44
Stem cell therapy; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissuesblood and cells; medical treatment and diagnosis in the nature of regenerative therapy by culture of medical and clinical cells; medical care; providing information and data for diagnosis and medical treatment in the nature of medical information; medical treatment or diagnosis in the nature of regenerative therapy using regenerative medicine; medical treatment or diagnosis in the nature of regenerative cell therapy; medical treatment in the nature of regenerative therapy; professional medical consulting services in the field of cell preparations to treat diseases; preservation of human blood for use as a supply source of stem cells; clinical examination in the nature of medical examination services; provision of patient clinical medical information and medical record analysis for use in medical treatmentdiagnosis and prevention; medical treatment in the nature of regenerative therapy using cultured cells; preparation and dispensing of medications; physical examination services; dentistry services; providing health information; dietary and nutritional guidance; rental of medical apparatus; commissioned cell culture services for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
26/07/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
25/07/2022
PLGL
ASSIGNED TO PARALEGAL
25/07/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
25/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/01/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/12/2021
FIMP
FINAL DISPOSITION PROCESSED
22/12/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/11/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/11/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/05/2021
PUBO
PUBLISHED FOR OPPOSITION
18/05/2021
GPNX
NOTIFICATION PROCESSED BY IB
17/05/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28/04/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
28/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/04/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
27/11/2020
RFNT
REFUSAL PROCESSED BY IB
22/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/10/2020
RFRR
REFUSAL PROCESSED BY MPU
29/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/10/2020
CNRT
NON-FINAL ACTION WRITTEN
05/10/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/10/2020
DOCK
ASSIGNED TO EXAMINER
28/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/09/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MY IPS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.